Cytoprotective effects of silymarin on epithelial cells against arsenic-induced apoptosis in contrast with quercetin cytotoxicity

Life Sciences

Volumn 87, Issue 9-10, 2010, Pages 309-315

  Soria, Elio A ^a,b,c   Eynard, Aldo R ^a,c   Bongiovanni, Guillermina A ^c,d  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d UNIVERSIDAD NACIONAL DEL COMAHUE   (Argentina)

Author keywords

Antioxidant; Apoptosis; Arsenite; Cytoprotection; Oxidative stress; Quercetin; Silymarin

Indexed keywords

ARSENIC; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE 10; PHOSPHATIDYLSERINE; QUERCETIN; SILYMARIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; APOPTOSIS; ARSENITES; CASPASES; CHO CELLS; CRICETINAE; CRICETULUS; CYTOPROTECTION; EPITHELIAL CELLS; FLOW CYTOMETRY; HYDROGEN PEROXIDE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICROSCOPY, FLUORESCENCE; OXIDATIVE STRESS; PROTECTIVE AGENTS; QUERCETIN; SILYMARIN; SODIUM COMPOUNDS;

EID: 77955773776     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.07.007     Document Type: Article

References (37)

1. Amadori S., Fenaux P., Ludwig H., O'dwyer M., Sanz M. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent. Current Medical Research and Opinion 2005, 21:403-411.
2. Arya R., Mallik M., Lakhotia S.C. Heat shock genes - integrating cell survival and death. Journal of Biosciences 2007, 32:595-610.
3. Bode A.M., Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Critical Reviews in Oncology and Hematology 2002, 42:5-24.
4. Bongiovanni G.A., Cantero J.J., Eynard A.R., Goleniowski M.E. Organic extracts of Larrea divaricata Cav. induced apoptosis on tumoral MCF7 cells with an higher citotoxicity than nordihydroguaiaretic acid or paclitaxel. Journal of Experimental Therapeutics and Oncology 2008, 7:1-7.
5. Bongiovanni G.A., Soria E.A., Eynard A.R. Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells. Food and Chemical Toxicology 2007, 45:971-976.
6. Bowling B.D., Doudican N., Manga P., Orlow S.J. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Cancer Chemotherapy and Pharmacology 2008, 63:37-43.
7. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976, 72:248-254.
8. Collins J.A., Schandl C.A., Young K.K., Vesely J., Willingham M.C. Major DNA fragmentation is a late event in apoptosis. The Journal of Histochemistry and Cytochemistry 1997, 45:923-934.
9. 4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9. BMC Biotechnology 2009, 9:84.
10. Franco R., Sánchez-Olea R., Reyes-Reyes E.M., Panayiotidis M.I. Environmental toxicity, oxidative stress and apoptosis: Ménage à Trois. Mutation Research 2009, 674:3-22.
11. Grandmaison P.A., Nanowski T.S., Vance J.E. Externalization of phosphatidylserine during apoptosis does not specifically require either isoform of phosphatidylserine synthase. Biochimica et Biophysica Acta 2004, 1636:1-11.
12. Gurtu V., Kain S.R., Zhang G. Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Analytical Biochemistry 1997, 251:98-102.
13. Habib G.M., Shi Z.Z., Lieberman M.W. Glutathione protects cells against arsenite-induced toxicity. Free Radical Biology and Medicine 2007, 42:191-201.
14. He X.Q., Chen R., Yang P., Li A.P., Zhou J.W., Liu Q.Z. Biphasic effect of arsenite on cell proliferation and apoptosis is associated with the activation of JNK and ERK1/2 in human embryo lung fibroblast cells. Toxicology and Applied Pharmacology 2007, 220:18-24.
15. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2004, 84:1-477.
16. Kang Y.H., Lee S.J. The role of p38 MAPK and JNK in arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. Journal of Cellular Physiology 2008, 217:23-33.
17. Komissarova E.V., Saha S.K., Rossman T.G. Dead or dying: the importance of time in cytotoxicity assays using arsenite as an example. Toxicology and Applied Pharmacology 2005, 202:99-107.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophago T4. Nature 1970, 227:680-685.
19. Lau A.T., Li M., Xie R., He Q.Y., Chiu J.F. Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells. Carcinogenesis 2004, 25:21-28.
20. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 2003, 25:17-24.
21. Lin J.K. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Archives of Pharmacal Research 2002, 25:561-571.
22. Liu J., Lu Y., Wu Q., Goyer R.A., Waalkes M.P. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite. The Journal of Pharmacology and Experimental Therapeutics 2008, 326:363-368.
23. McCullagh P., Nelder J.A. Generalized Linear Models 1989, Chapman & Hall, London. second ed.
24. Mishra D., Flora S.J. Quercetin administration during chelation therapy protects arsenic-induced oxidative stress in mice. Biological Trace Element Research 2008, 122:137-147.
25. Moon Y.J., Wang X., Morris M.E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicology In Vitro 2006, 20:187-210.
26. Nakane P.K. Simultaneous localization of multiple tissue antigens using the peroxidase-labelled antibody method: a study on pituitary glands of the rat. The Journal of Histochemistry and Cytochemistry 1968, 16:557-560.
27. Park A.M., Dong Z. Signal transduction pathways: targets for green and black tea polyphenols. Journal of Biochemistry and Molecular Biology 2003, 36:66-77.
28. Ramos A.M., Aller P. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukaemia cell lines. Biochemical Pharmacology 2008, 75:1912-1923.
29. 3 toxicity in rat hepatocytes: manifestation of caspase-mediated apoptosis. Toxicology and Industrial Health 2008, 24:643-653.
30. Rubatto Birri P.N., Pérez R.D., Cremonezzi D.C., Pérez C.A., Rubio M., Bongiovanni G.A. Association between Fe, Cu, Zn and As accumulation along renal cortex and physiological and histological alterations after chronic arsenic intake. Environmental Research 2010, 110:417-423.
31. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997, 89:3354-3360.
32. Soria E.A., Eynard A.R., Quiroga P.L., Bongiovanni G.A. Differential effects of quercetin and silymarin on arsenite-induced cytotoxicity in two human breast adenocarcinoma cell lines. Life Sciences 2007, 81:1397-1402.
33. Soria E.A., Goleniowski M.E., Cantero J.J., Bongiovanni G.A. Antioxidant activity of different extracts of Argentinian medicinal plants against arsenic-induced toxicity in renal cells. Human and Experimental Toxicology 2008, 27:341-346.
34. Talanian R.V., Quinlan C., Trautz S., Hackett M.C., Mankovich J.A., Banach D., Ghayur T., Brady K.D., Wong W.W. Substrate specificities of caspase family proteases. The Journal of Biological Chemistry 1997, 272:9677-9682.
35. Tseng C.H. A review on environmental factors regulating arsenic methylation in humans. Toxicology and Applied Pharmacology 2009, 235:338-350.
36. Tsujimoto M., Horie M., Honda H., Takara K., Nishiguchi K. The structure-activity correlation on the inhibitory effects of flavonoids on cytochrome P450 3A activity. Biological and Pharmaceutical Bulletin 2009, 32:671-676.
37. Wang C.H., Hsiao C.K., Chen C.L., Hsu L.I., Chiou H.Y., Chen S.Y., Hsueh Y.M., Wu M.M., Chen C.J. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicology and Applied Pharmacology 2007, 222:315-326.